Novo Biosciences, Inc.

New Filing
CIK: 0001648277·Biotechnology·DELAWARE·Filed: Jun 9, 2020
Total Offering

$4,000,000

Amount Sold

$4,000,000

Investors

1

First Sale

May 28, 2020

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Kevin Strange
Related Person
Viravuth Yin
Related Person

Company

Novo Biosciences, Inc.

22 Partridge Cove Road

Lamoine, ME, 04605

(202) 669 0208

SEC Filing

0001415889-20-001530

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Novo Biosciences, Inc. Form D Filing — $4,000,000 | FilingFlow